Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide , based on Phase 2 data, shares adverse effects with other GLP-1-based therapies
Exploratory protocols thus gain unique signaling benefit at the cost of more demanding monitoring complexity.
however, it piqued significant public and commercial interest in 2021 when the STEP-1 trial demonstrated up to 14% placebo-adjusted weight loss, leading to its approval as a weight loss drug, Wegovy
Youve been diagnosed with multiple endocrine neoplasia syndrome type 2 (MEN 2) : This rare genetic condition predisposes individuals to certain cancers, including MTC
Looking Back on GLP-1 RAs Originally discovered in the saliva of the Gila monster, exenatide a GLP-1 RA was approved as a twice-daily injection by the FDA in 2005 for adults with type 2 diabetes
106.4 Development and Validation of the Postoperative Recovery Assessment in Lung Cancer (PRA_Lung): A Modular Patient-Reported Outcome Measure Cheng Lei 1 , Hongfan Yu 2 , Wen Zhou 2 , Qiuling Shi 2 1 Sichuan Cancer Hospital and Institute, Chengdu, China, 2 State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :106.4 Aims This study aimed to develop and validate a modular patient-reported outcome measure (PROM) for assessing postoperative recovery in lung cancer patients, integrating symptom burden and functional interference domains while prioritizing patient-centered perspectives
US$ 20.03
US$ 27.95
US$ 27.38
US$ 26.56
US$ 24.59
US$ 21.15
